Skip to Content

Notice

Importer of Controlled Substances; Notice of Application

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.

Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on March 14, 2008, Research Triangle Institute, Kenneth H. Davis Jr., Hermann Building, East Institute Drive, P.O. Box 12194, Research Triangle, North Carolina 27709, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II:

DrugSchedule
1-(1-Phenylcyclohexyl)pyrrolidine (7458)I
1-[1-(2-Thienyl)cyclohexy]piperidine (7470)I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine (7473)I
1-Methyl-4-phenyl-4-propionoxypiperidine (9661)I
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine (9663)I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348)I
2,5-Dimethoxy-4-ethylamphetamine (7399)I
2,5-Dimethoxyamphetamine (7396)I
3,4,5-Trimethoxyamphetamine (7390)I
3,4-Methylenedioxyamphetamine (7400)I
3,4-Methylenedioxymethamphetamine (7405)I
3,4-Methylenedioxy-N-ethylamphetamine (7404)I
3-Methylfentanyl (9813)I
3-Methylthiofentanyl (9833)I
4-Bromo-2,5-dimethoxyamphetamine (7391)I
4-Bromo-2,5-dimethoxyphenethylamine (7392)I
4-Methyl-2,5-dimethoxyamphetamine (7395)I
4-Methylaminorex (cis isomer) (1590)I
4-Methoxyamphetamine (7411)I
5-Methoxy-3,4-methylenedioxyamphetamine (7401)I
Start Printed Page 20716
5-Methoxy-N,N-diisopropyltryptamine (7439)I
Acetorphine (9319)I
Acetyl-alpha-methylfentanyl (9815)I
Acetyldihydrocodeine (9051)I
Acetylmethadol (9601)I
Allylprodine (9602)I
Alphacetylmethadol except levo-alphacetylmethadol (9603)I
Alpha-ethyltryptamine (7249)I
Alphameprodine (9604)I
Alphamethadol (9605)I
Alpha-methylfentanyl (9814)I
Alpha-methylthiofentanyl (9832)I
Alpha-methyltryptamine (7432)I
Aminorex (1585)I
Benzethidine (9606)I
Benzylmorphine (9052)I
Betacetylmethadol (9607)I
Beta-hydroxy-3-methylfentanyl (9831)I
Beta-hydroxyfentanyl (9830)I
Betameprodine (9608)I
Betamethadol (9609)I
Betaprodine (9611)I
Bufotenine (7433)I
Cathinone (1235)I
Clonitazene (9612)I
Codeine methylbromide (9070)I
Codeine-N-Oxide (9053)I
Cyprenorphine (9054)I
Desomorphine (9055)I
Dextromoramide (9613)I
Diampromide (9615)I
Diethylthiambutene (9616)I
Diethyltryptamine (7434)I
Difenoxin (9168)I
Dihydromorphine (9145)I
Dimenoxadol (9617)I
Dimepheptanol (9618)I
Dimethylthiambutene (9619)I
Dimethyltryptamine (7435)I
Dioxaphetyl butyrate (9621)I
Dipipanone (9622)I
Drotebanol (9335)I
Ethylmethylthiambutene (9623)I
Etonitazene (9624)I
Etorphine except HCl (9056)I
Etoxeridine (9625)I
Fenethylline (1503)I
Furethidine (9626)I
Gamma Hydroxybutyric Acid (2010)I
Heroin (9200)I
Hydromorphinol (9301)I
Hydroxypethidine (9627)I
Ibogaine (7260)I
Ketobemidone (9628)I
Levomoramide (9629)I
Levophenacylmorphan (9631)I
Lysergic acid diethylamide (7315)I
Marihuana (7360)I
Mecloqualone (2572)I
Mescaline (7381)I
Methaqualone (2565)I
Methcathinone (1237)I
Methyldesorphine (9302)I
Methyldihydromorphine (9304)I
Morpheridine (9632)I
Morphine methylbromide (9305)I
Morphine methylsulfonate (9306)I
Morphine-N-Oxide (9307)I
Myrophine (9308)I
N,N-Dimethylamphetamine (1480)I
N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (9834)I
N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (9818)I
N-Benzylpiperazine (7493)I
N-Ethyl-3-piperidyl benzilate (7482)I
Start Printed Page 20717
N-Ethylamphetamine (1475)I
N-Ethyl-l-phenylcyclohexylamine (7455)I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)I
Nicocodeine (9309)I
Nicomorphine (9312)I
N-Methyl-3-piperidyl benzilate (7484)I
Noracymethadol (9633)I
Norlevorphanol (9634)I
Normethadone (9635)I
Normorphine (9313)I
Norpipanone (9636)I
Para-Fluorofentanyl (9812)I
Parahexyl (7374)I
Peyote (7415)I
Phenadoxone (9637)I
Phenampromide (9638)I
Phenomorphan (9647)I
Phenoperidine (9641)I
Pholcodine (9314)I
Piritramide (9642)I
Proheptazine (9643)I
Properidine (9644)I
Propiram (9649)I
Psilocybin (7437)I
Psilocyn (7438)I
Racemoramide (9645)I
Tetrahydrocannabinols (7370)I
Thebacon (9315)I
Thiofentanyl (9835)I
Tilidine (9750)I
Trimeperidine (9646)I
1-Phenylcyclohexylamine (7460)II
1-Piperidinocyclohexanecarbonitrile (8603)II
Alfentanil (9737)II
Alphaprodine (9010)II
Amobarbital (2125)II
Amphetamine (1100)II
Anileridine (9020)II
Bezitramide (9800)II
Carfentanil (9743)II
Codeine (9050)II
Dextropropoxyphene, bulk (non-dosage forms) (9273)II
Dihydrocodeine (9120)II
Dihydroetorphine (9334)II
Diphenoxylate (9170)II
Ethylmorphine (9190)II
Etorphine Hcl (9059)II
Fentanyl (9801)II
Glutethimide (2550)II
Hydrocodone (9193)II
Hydromorphone (9150)II
Isomethadone (9226)II
Levo-alphacetylmethadol (9648)II
Levomethorphan (9210)II
Levorphanol (9220)II
Lisdexamfetamine (1205)II
Meperidine (9230)II
Meperidine intermediate—A (9232)II
Meperidine intermediate—B (9233)II
Meperidine intermediate—C (9234)II
Metazocine (9240)II
Methadone (9250)II
Methadone intermediate (9254)II
Methamphetamine (1105)II
Methylphenidate (1724)II
Metopon (9260)II
Moramide intermediate (9802)II
Morphine (9300)II
Nabilone (7379)II
Opium, raw (9600)II
Opium extracts (9610)II
Opium fluid extract (9620)II
Opium tincture (9630)II
Opium, granulated (9640)II
Start Printed Page 20718
Oxycodone (9143)II
Oxymorphone (9652)II
Pentobarbital (2270)II
Phenazocine (9715)II
Phencyclidine (7471)II
Phenmetrazine (1631)II
Phenylacetone (8501)II
Piminodine (9730)II
Powdered opium (9639)II
Racemethorphan (9732)II
Racemorphan (9733)II
Remifentanil (9739)II
Secobarbital (2315)II
Sufentanil (9740)II
Thebaine (9333)II

The company plans to import small quantities of the listed controlled substances for the National Institute on Drug Abuse (NIDA) for research activities.

Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47.

Any such comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than May 16, 2008.

This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745-46), all applicants for registration to import a basic class of any controlled substances in schedule I or II are and will continue to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.

Start Signature

Dated: April 9, 2008.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. E8-8177 Filed 4-15-08; 8:45 am]

BILLING CODE 4410-09-P